Reactive Oxygen Species Explicit dosimetry for Pleural PDT

Timothy C. Zhu,Hongjing Sun,Weibing Yang,Andreea Dimofte,Sunil Singhal,Keith A. Cengel
DOI: https://doi.org/10.1016/j.pdpdt.2024.104164
IF: 3.577
2024-05-30
Photodiagnosis and Photodynamic Therapy
Abstract:Significance Preclinical studies show improved prediction of treatment outcome using [ROS] rx than light fluence rate or PDT dose. We demonstrate ROSED in a clinical setting. Approach Explicit dosimetry of light fluence, photosensitizer concentration, and oxygen concentration is used to quantify the reactive oxygen species explicit dosimetry (ROSED) during Photofrin-mediated pleural PDT. Light fluence and photosensitizer concentration were measured by a customized multi-channel PDT dose dosimeter system. Diffuse correlation spectroscopy (DCS) contact probes were sutured to the pleural cavity wall after surgical resection of pleural mesothelioma tumor to monitor tissue blood flow (BFI) during intraoperative PDT treatment. Tissue oxygen concentration can be determined by utilizing tumor blood flow measured by DCS. Results Large inter- and intra-patient heterogeneities in [ROS] rx were observed although an identical light dose of 60 J/cm 2 was prescribed to all patients. Conclusions This study summarizes the current results of ROSED for a Phase II pleural PDT clinical trial.
oncology
What problem does this paper attempt to address?